Status:
NO_LONGER_AVAILABLE
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Hepatitis B
Chronic Disease
Eligibility:
All Genders
16+ years
Brief Summary
The purpose of this clinical research study is to provide entecavir to subjects with chronic Hepatitis B infection who have failed or who have demonstrated intolerance of marketed therapies or for tho...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hepatitis B Early Access Program
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
EXPANDED_ACCESS
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00096811
Start Date
September 1 2003
End Date
August 1 2008
Last Update
September 21 2016
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Jerusalem, Israel, 91120
2
Local Institution
Nazareth, Israel, 16100
3
Local Institution
Petah Tikva, Israel, 49100
4
Local Institution
Safed, Israel, 13110